RenovoRx, Inc.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving RenovoRx, Inc. now
Current reporting with the operating signal separated from the noise.
RenovoRx, Inc. (RNXT) Q1 2026 Earnings Call Transcript
Investors are testing whether RenovoRx, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.RenovoRx, Inc. (RNXT) may report negative earnings: Know the trend ahead of next week's release
Investors are testing whether RenovoRx, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.RenovoRx, Inc.: RenovoRx Reports Full Year 2025 Financial Results and Provides Business Update
The story matters when it changes RenovoRx, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.RenovoRx, Inc. (RNXT) Q1 2025 Earnings Conference Call Transcript
Investors are testing whether RenovoRx, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Analysts Expect Breakeven For RenovoRx, Inc. (NASDAQ:RNXT) Before Long
The story matters when it changes RenovoRx, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Latest RNXT filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
RenovoRx, Inc., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
Second quarter
No verified period-specific item in the current feed.
SEARCH Q2 COVERAGE →Third quarter
No verified period-specific item in the current feed.
SEARCH Q3 COVERAGE →